What is the official website of Merck Group ?

The official website of Merck Group is http://www.merckgroup.com.

What is Merck Group's cybersecurity risk score?

Merck Group has an AI-generated cybersecurity risk score of 686 out of 1000, indicating a Weak security posture according to Rankiteo's assessment.

How many security incidents has Merck Group experienced?

According to Rankiteo, Merck Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Merck Group been affected by any supply chain cyber incidents ?

According to Rankiteo, Merck Group has been affected by a supply chain cyber incident involving Snowflake, with the incident ID MEREQUUNIMAEMGMGOOTOYSNOALLORARIPTIC1775528897.

Does Merck Group have SOC 2 Type 1 certification ?

According to Rankiteo, Merck Group is not certified under SOC 2 Type 1.

Does Merck Group have SOC 2 Type 2 certification ?

According to Rankiteo, Merck Group does not hold a SOC 2 Type 2 certification.

Does Merck Group comply with GDPR ?

According to Rankiteo, Merck Group is not listed as GDPR compliant.

Does Merck Group have PCI DSS certification ?

According to Rankiteo, Merck Group does not currently maintain PCI DSS compliance.

Does Merck Group comply with HIPAA ?

According to Rankiteo, Merck Group is not compliant with HIPAA regulations.

Does Merck Group have ISO 27001 certification ?

According to Rankiteo,Merck Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Merck Group operate in ?

Merck Group operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Merck Group have ?

Merck Group employs approximately 32,268 people worldwide.

Does Merck Group own any subsidiaries ?

Merck Group presently has no subsidiaries across any sectors.

How many LinkedIn followers does Merck Group have ?

Merck Group's official LinkedIn profile has approximately 1,643,572 followers.

What is the NAICS classification code for Merck Group ?

Merck Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Merck Group have a Crunchbase profile ?

No, Merck Group does not have a profile on Crunchbase.

Does Merck Group have a LinkedIn profile ?

Yes, Merck Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/merck-group.

How many cybersecurity incidents has Merck Group experienced ?

As of October 13, 2026, Rankiteo reports that Merck Group has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Merck Group have ?

Merck Group has an estimated 5,775 peer or competitor companies worldwide.

What types of cybersecurity incidents has Merck Group faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Merck Group

Boost Score +25 with badge (5 left)

686

/1000

Weak

711

/1000

Moderate

Merck Group Vendor Cyber Rating & Cyber Score

merckgroup.com

Add Your Compliance Badge

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about

Merck Group

Merck Group CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Merck Group

Ransomware

100

12/2025

Snowflake

MEREQUUNIMAEMGM...

Loading…

A.I.

Merck Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Merck Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Group in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Merck Group in 2026.

Incident Types Merck Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Group in 2026.

Incident History - Merck Group (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Merck Group Subsidiaries

Merck Group

Pharmaceutical Manufacturing

Website: http://www.merckgroup.com

Company Size: 10,000+ employees

Merck Life ScienceBiotechnology Research

Merck HealthcarePharmaceutical Manufacturing

Merck ElectronicsChemical Manufacturing

Loading…

Merck Group Similar Companies

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Loading…

NEWS

Merck Group CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 19, 2026 07:00 AM

How The Investment Story For Merck KGaA (XTRA:MRK) Is Quietly Shifting On Cautious Targets

A small reset in fair value to €143.20, together with individual analyst targets moving to €135 from €150 and to €130 from €125,...

Read Article

March 06, 2026 08:00 AM

Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings

It projected lower adjusted earnings and flat sales at best for 2026.

Read Article

March 05, 2026 08:00 AM

Merck KGaA Q4 Earnings Call Highlights

Merck KGaA (ETR:MRK) executives told investors the company delivered “solid” organic growth in 2025 despite a challenging macroeconomic and...

Read Article

March 05, 2026 08:00 AM

Merck KGaA sees earnings drop on currency effects, MS drug

Germany's Merck KGaA projected 2026 adjusted operating profit to slip by as much as 9.8%, hurt by negative currency effects and the loss of...

Read Article

March 03, 2026 08:00 AM

List of Fortune 500 Chief Information Security Officers

Every one of our nation's biggest businesses has a cybersecurity leader. Scroll down the list to see who's who.

Read Article

January 14, 2026 08:00 AM

Is Merck KGaA (XTRA:MRK) Share Price Misaligned With Cash Flow And Earnings Valuation Estimates

If you are wondering whether Merck KGaA is offering fair value at its current share price, this article will walk you through what the...

Read Article

November 20, 2025 08:00 AM

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's...

Read Article

November 13, 2025 08:00 AM

Germany’s Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results

The company's life-science segment—its largest by sales—benefited from strong demand from the pharma industry, continuing a recovery...

Read Article

November 12, 2025 08:00 AM

Merck KGaA's Q3 profit rises, beats market view

Merck KGaA on Thursday reported a slight gain in third-quarter operating earnings that beat market expectations, benefiting from legislative...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93892

SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7292035

CVE-2026-93891

SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 7.6)

cvss3

Base Score: 7.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:L

Impact Score

4.7

Exploitability

2.3

REFERENCES

https://www.ibm.com/support/pages/node/7292036

CVE-2026-92832

SUMMARY

IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 5.1)

cvss3

Base Score: 5.1

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

2.5

REFERENCES

https://www.ibm.com/support/pages/node/7291755

CVE-2026-85457

SUMMARY

IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7291604

CVE-2026-84418

SUMMARY

IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.2

REFERENCES

https://www.ibm.com/support/pages/node/7288649

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Merck Group Vendor Cyber Rating & Cyber Score

Merck Group A.I CyberSecurity Scoring

Merck Group CyberSecurity News & History

Merck Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Merck Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Merck Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Merck Group (X = Date, Y = Severity)

Merck Group Subsidiaries

Merck Group

Merck Group Similar Companies

Johnson & Johnson Innovative Medicine

Ipca Laboratories Limited

Fresenius Kabi

Novo Nordisk

Teva Pharmaceuticals

Lupin

Sandoz

Grifols

Bristol Myers Squibb

Merck Group CyberSecurity News

How The Investment Story For Merck KGaA (XTRA:MRK) Is Quietly Shifting On Cautious Targets

Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings

Merck KGaA Q4 Earnings Call Highlights

Merck KGaA sees earnings drop on currency effects, MS drug

List of Fortune 500 Chief Information Security Officers

Is Merck KGaA (XTRA:MRK) Share Price Misaligned With Cash Flow And Earnings Valuation Estimates

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal

Germany’s Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results

Merck KGaA's Q3 profit rises, beats market view

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Merck Group CyberSecurity News & History

Merck Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Merck Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Merck Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Merck Group (X = Date, Y = Severity)

Merck Group Subsidiaries

Merck Group

Merck Group Similar Companies

Johnson & Johnson Innovative Medicine

Ipca Laboratories Limited

Fresenius Kabi

Novo Nordisk

Teva Pharmaceuticals

Lupin

Sandoz

Grifols

Bristol Myers Squibb

Merck Group CyberSecurity News

How The Investment Story For Merck KGaA (XTRA:MRK) Is Quietly Shifting On Cautious Targets

Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings

Merck KGaA Q4 Earnings Call Highlights

Merck KGaA sees earnings drop on currency effects, MS drug

List of Fortune 500 Chief Information Security Officers

Is Merck KGaA (XTRA:MRK) Share Price Misaligned With Cash Flow And Earnings Valuation Estimates

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal

Germany’s Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results

Merck KGaA's Q3 profit rises, beats market view

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo